Andre L Moreira

Summary

Affiliation: New York University
Country: USA

Publications

  1. ncbi request reprint Metastatic "borderline" papillary ovarian tumor in an intramammary lymph node
    Andre L Moreira
    Department of Pathology, New York University Medical Center, New York, New York 10016, USA
    Breast J 8:309-10. 2002
  2. ncbi request reprint Aspiration cytology of the oncocytic variant of papillary adenocarcinoma of the thyroid gland
    Andre L Moreira
    Division of Cytopathology, Department of Pathology, New York University School of Medicine, New York, New York, USA
    Acta Cytol 48:137-41. 2004
  3. doi request reprint Subtyping of non-small cell lung carcinoma: a comparison of small biopsy and cytology specimens
    Carlie S Sigel
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, New York 10065, USA
    J Thorac Oncol 6:1849-56. 2011
  4. doi request reprint Predicting pulmonary adenocarcinoma outcome based on a cytology grading system
    Carlie S Sigel
    1Memorial Sloan Kettering Cancer Center, Department of Pathology, New York, New York, USA
    Cancer Cytopathol 120:35-43. 2012
  5. doi request reprint Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens
    Natasha Rekhtman
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Mod Pathol 24:1348-59. 2011
  6. doi request reprint A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma
    Kyuichi Kadota
    Division of Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Mod Pathol 25:1117-27. 2012
  7. doi request reprint Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing
    Natasha Rekhtman
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, New York 10065, USA
    J Thorac Oncol 6:451-8. 2011
  8. pmc Correlation of a priori DCE-MRI and (1)H-MRS data with molecular markers in neck nodal metastases: Initial analysis
    Jacobus F A Jansen
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Oral Oncol 48:717-22. 2012
  9. doi request reprint Progenitor stem cell marker expression by pulmonary carcinomas
    Andre L Moreira
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Mod Pathol 23:889-95. 2010
  10. ncbi request reprint Histologic features are important prognostic indicators in early stages lung adenocarcinomas
    Joon Yim
    Department of Pathology, New York University School of Medicine, New York, NY, USA
    Mod Pathol 20:233-41. 2007

Collaborators

Detail Information

Publications27

  1. ncbi request reprint Metastatic "borderline" papillary ovarian tumor in an intramammary lymph node
    Andre L Moreira
    Department of Pathology, New York University Medical Center, New York, New York 10016, USA
    Breast J 8:309-10. 2002
  2. ncbi request reprint Aspiration cytology of the oncocytic variant of papillary adenocarcinoma of the thyroid gland
    Andre L Moreira
    Division of Cytopathology, Department of Pathology, New York University School of Medicine, New York, New York, USA
    Acta Cytol 48:137-41. 2004
    ..To study the cytologic features of the oncocytic variant of papillary adenocarcinoma of the thyroid gland to distinguish this subtype from other oncocytic lesions of the thyroid...
  3. doi request reprint Subtyping of non-small cell lung carcinoma: a comparison of small biopsy and cytology specimens
    Carlie S Sigel
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, New York 10065, USA
    J Thorac Oncol 6:1849-56. 2011
    ..The relative feasibility and accuracy of NSCLC subtyping by small biopsy versus cytology is not well established, particularly in current practice where immunohistochemistry (IHC) is becoming routinely used to aid in this distinction...
  4. doi request reprint Predicting pulmonary adenocarcinoma outcome based on a cytology grading system
    Carlie S Sigel
    1Memorial Sloan Kettering Cancer Center, Department of Pathology, New York, New York, USA
    Cancer Cytopathol 120:35-43. 2012
    ..Therefore, we evaluated cytomorphologic features of previously histologically graded AD to identify features of potential prognostic significance...
  5. doi request reprint Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens
    Natasha Rekhtman
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Mod Pathol 24:1348-59. 2011
    ..This simple algorithm achieves excellent accuracy in small specimens while conserving the tissue for potential predictive marker testing, which is now an essential consideration in advanced lung cancer specimens...
  6. doi request reprint A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma
    Kyuichi Kadota
    Division of Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Mod Pathol 25:1117-27. 2012
    ..005) after adjusting for clinical factors. We proposed this combined architectural/mitotic grade for lung adenocarcinoma as a practical method that can be applied in routine practice...
  7. doi request reprint Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing
    Natasha Rekhtman
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, New York 10065, USA
    J Thorac Oncol 6:451-8. 2011
    ..The aim of this study was to comprehensively review the performance of cytologic specimens for the above two goals in a high-volume clinical practice...
  8. pmc Correlation of a priori DCE-MRI and (1)H-MRS data with molecular markers in neck nodal metastases: Initial analysis
    Jacobus F A Jansen
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Oral Oncol 48:717-22. 2012
    ..Future studies with larger patient populations need to be carried out to validate and clarify our preliminary findings...
  9. doi request reprint Progenitor stem cell marker expression by pulmonary carcinomas
    Andre L Moreira
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Mod Pathol 23:889-95. 2010
    ..Therefore, stem cell markers are expressed in lung cancers with different patterns seen for different histological types and degrees of differentiation...
  10. ncbi request reprint Histologic features are important prognostic indicators in early stages lung adenocarcinomas
    Joon Yim
    Department of Pathology, New York University School of Medicine, New York, NY, USA
    Mod Pathol 20:233-41. 2007
    ..These results are helpful in defining a subcategory of 'minimally invasive adenocarcinoma', which has features similar to bronchioloalveolar carcinoma...
  11. pmc Response to erlotinib in patients with EGFR mutant advanced non-small cell lung cancers with a squamous or squamous-like component
    Paul K Paik
    Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, 300 East 66 Street, New York, NY 10065, USA
    Mol Cancer Ther 11:2535-40. 2012
    ..These tumors can mimic SCC in small samples. We propose an approach to increase the capture of these rare histology patients for EGFR mutation testing...
  12. pmc Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma
    Natasha Rekhtman
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Mod Pathol 26:511-22. 2013
    ..These findings have practical implications for diagnosis, predictive molecular testing and therapy selection...
  13. pmc Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations
    Natasha Rekhtman
    Department of Pathology, Thoracic Oncology Service, Department of Medicine, and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, NY 10065, USA
    Clin Cancer Res 18:1167-76. 2012
    ....
  14. doi request reprint Molecular characterization by immunocytochemistry of lung adenocarcinoma on cytology specimens
    Andre L Moreira
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Acta Cytol 56:603-10. 2012
    ....
  15. doi request reprint Use of mutation specific antibodies to detect EGFR status in small biopsy and cytology specimens of lung adenocarcinoma
    Adnan Hasanovic
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Lung Cancer 77:299-305. 2012
    ..Specific antibodies that can detect mutant EGFR protein were evaluated for the detection of EGFR mutation by immunohistochemistry (IHC) in cytology and small biopsy specimens...
  16. doi request reprint A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors
    Gabriel Sica
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Am J Surg Pathol 34:1155-62. 2010
    ..65 (95% confidence interval 0.57-0.73). Therefore, this scoring system provides valuable information in discriminating patients with different risk of disease-recurrence in a highly homogeneous population of patients with stage I cancer...
  17. doi request reprint Extrauterine epithelioid trophoblastic tumors presenting as primary lung carcinomas: morphologic and immunohistochemical features to resolve a diagnostic dilemma
    Sharyn N Lewin
    Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Am J Surg Pathol 33:1809-14. 2009
    ..Correlating clinical indices with specific morphologic and immunohistochemical features can ensure diagnostic accuracy and appropriate treatment for favorable outcomes...
  18. doi request reprint Primary lung adenocarcinomas in children and adolescents treated for pediatric malignancies
    Mark L Kayton
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Thorac Oncol 5:1764-71. 2010
    ..Herein, we present clinical, histopathologic, and molecular data on eight such cases...
  19. doi request reprint Immunohistochemical staining with EGFR mutation-specific antibodies: high specificity as a diagnostic marker for lung adenocarcinoma
    Yong Hannah Wen
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Mod Pathol 26:1197-203. 2013
    ..Our results show that EGFR mutation-specific antibodies could be an additional tool distinguishing primary versus metastatic carcinomas in the lung. False-positivity can be seen in breast carcinoma but is extremely rare (1%). ..
  20. pmc Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases
    Amita Shukla-Dave
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Radiat Oncol Biol Phys 82:1837-44. 2012
    ..The goal of this study was to assess the prognostic value of pretreatment DCE-MRI in head and neck squamous cell carcinoma (HNSCC) patients with nodal disease undergoing chemoradiation therapy or surgery...
  21. doi request reprint Cytologic diagnosis of pulmonary adenocarcinoma with micropapillary pattern: does it correlate with the histologic findings?
    Dorota E Rudomina
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Diagn Cytopathol 37:333-9. 2009
    ..Similar findings were observed for other invasive patterns. Therefore, the detection of micropapillary tufts in cytology is not specific for the diagnosis of a pulmonary micropapillary adenocarcinoma in the lung...
  22. doi request reprint Personalized medicine for non-small-cell lung cancer: implications of recent advances in tissue acquisition for molecular and histologic testing
    Andre L Moreira
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Clin Lung Cancer 13:334-9. 2012
    ..Recent advances in tissue acquisition techniques and specimen preservation may help to address this challenge and lead to enhanced personalized treatment in NSCLC...
  23. pmc Advances in fine needle aspiration cytology for the diagnosis of pulmonary carcinoma
    Adnan Hasanovic
    Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Patholog Res Int 2011:897292. 2011
    ..In this paper we will review the current concepts in the suitability and accuracy of fine needle aspiration biopsy, including diagnosis, classification, prognostic markers, and use of ancillary techniques...
  24. doi request reprint Diagnostic pitfalls in fine needle aspiration biopsy of the spleen
    Maria A Friedlander
    Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Diagn Cytopathol 36:69-75. 2008
    ..The use of ancillary studies is important in the definitive classification of benign and malignant splenic lesions...
  25. ncbi request reprint Oropharyngeal aspiration of ricin as a lung challenge model for evaluation of the therapeutic index of antibodies against ricin A-chain for post-exposure treatment
    Timothy S Pratt
    Department of Environmental Medicine, New York University School of Medicine, Tuxedo, New York 10987, USA
    Exp Lung Res 33:459-81. 2007
    ....
  26. ncbi request reprint DC-LAMP stains pulmonary adenocarcinoma with bronchiolar Clara cell differentiation
    Lee Ching Zhu
    Department of Pathology, New York University School of Medicine, NY 10016, USA
    Hum Pathol 38:260-8. 2007
    ..There was no prognostic difference in tumors that reacted with DC-LAMP. DC-LAMP and CC-10 reactivity was also observed in endometrial adenocarcinomas but not in other tumor types...
  27. ncbi request reprint Cytomorphologic features of papillary lesions of the male breast: a study of 11 cases
    Michelle D Reid-Nicholson
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 108:222-30. 2006
    ..The patients ranged in age from 23 to 78 years old and each presented with an unilateral subareolar or periareolar breast mass that varied in size from 0.5 to 3 cm. Two patients presented with bloody nipple discharge...